Clinical efficacy of initial intratympanic steroid treatment on sudden sensorineural hearing loss with diabetes

Otolaryngology - Head and Neck Surgery

Volumn 141, Issue 5, 2009, Pages 572-578

  Han, Chi Sung ^a   Park, Jong Ryul ^a   Boo, Sung Hyun ^c   Jo, Joon Man ^a   Park, Kyung Won ^a   Lee, Won Yong ^a   Ahn, Joong Gi ^b   Kang, Myung Koo ^b   Park, Byung Gun ^d   Lee, Hyun ^e  

^a Wallace Memorial Baptist Hospital   (South Korea)

^b Dong A University   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d Busan St Mary's Medical Center   (South Korea)

^e Hana ORL Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOSE; PREDNISOLONE; PREDNISOLONE SODIUM SUCCINATE; SOLONDO; STEROID; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG DOSAGE FORM COMPARISON; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PERCEPTION DEAFNESS; PROSPECTIVE STUDY; SIDE EFFECT; SOUTH KOREA; STEROID THERAPY; SYSTEMIC THERAPY; TREATMENT DURATION;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; DEXAMETHASONE; DIABETIC ANGIOPATHIES; FEMALE; HEARING LOSS, SENSORINEURAL; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PREDNISOLONE; PROSPECTIVE STUDIES; STEROIDS; TREATMENT OUTCOME;

EID: 70350510618     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2009.06.084     Document Type: Article

References (20)

1. Shikowitz M.J. Sudden sensorineural hearing loss. Med Clin North Am 75 (1991) 1239-1250
2. Jorgensen M.B. The inner ear in diabetes mellitus. Arch Otolaryngol 74 (1961) 373-381
3. Costa O.A. Inner ear pathology in experimental diabetes. Laryngoscope 80 (1967) 68-75
4. Rust K.R., Prazma J., Triana R.J., et al. Inner ear damage secondary to diabetes mellitus. Arch Otolaryngol Head Neck Surg 118 (1992) 397-400
5. Weng S.F., Chen Y.S., Liu T.C., et al. Prognostic factors of sudden sensorineural hearing loss in diabetic patients. Diabetes Care 27 (2004) 2560-2561
6. Kakehata S., Sasaki A., Oji K., et al. Comparison of intratympanic and intravenous dexamethasone treatment on sudden sensorineural hearing loss with diabetes. Otol Neurotol 27 (2006) 604-608
7. Fukui M., Kitagawa Y., Nakamura N., et al. Idiopathic sudden hearing loss in patients with type 2 diabetes. Diabetes Res Clin Pract 63 (2004) 205-211
8. Foster D.W. Diabetes mellitus. In: Fauci A.S., Braunwald E., Kasper D.L., et al. (Eds). Harrison's principles of internal medicine. 17th ed. (2007), McGraw-Hill, New York 2275-2309
9. Conlin A.E., and Parnes L.S. Treatment of sudden sensorineural hearing loss: a meta-analysis. Arch Otolaryngol Head Neck Surg 133 (2007) 573-586
10. Fetterman B.L., Saunders J.E., and Luxford W.M. Prognosis and treatment of sudden sensorineural hearing loss. Am J Otol 17 (1996) 529-536
11. Parnes L.S., Sun A.H., and Freeman D.J. Corticosteroid pharmacokinetics in the inner ear fluids: animal study followed by clinical application. Laryngoscope 109 (1999) 1-17
12. Chandrasehkar S.S. Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation. Otol Neurotol 22 (2001) 18-23
13. Hargunani C.A., Kempton B., DeGagne J.M., et al. Intratympanic injection of dexamethasone: time course of inner ear distribution and conversion to its active form. Otol Neurotol 27 (2006) 564-569
14. Itoh A., and Sakata E. Treatment of vestibular disorders. Acta Otolaryngol Suppl 481 (1991) 617-623
15. Silverstein H., Choo D., Rosenberg S.I., et al. Intratympanic steroid treatment of inner ear disease and tinnitus. Ear Nose Throat J 75 (1996) 468-476
16. Choung Y.H., Park K.H., Shin Y.R., et al. Intratympanic dexamethasone injection for refractory sudden sensorineural hearing loss. Laryngoscope 116 (2006) 747-752
17. Haynes D.S., O'Malley M., Cohen S., et al. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Laryngoscope 117 (2007) 3-15
18. Xenellis J., Papadimitriou N., Nikolopoulos T., et al. Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study. Otolaryngol Head Neck Surg 134 (2006) 940-945
19. Battaglia A., Burchette R., and Cueva R. Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss. Otol Neurotol 29 (2008) 453-460
20. Ahn J.H., Yoo M.H., Yoon T.H., et al. Can intratympanic dexamethasone added to systemic steroids improve hearing outcome in patients with sudden deafness?. Laryngoscope 118 (2008) 279-282